Nederlands tijdschrift voor geneeskunde · 2026
[Home-administered therapy for hyperemesis gravidarum: an example of a successful transition of care from hospital to home].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
van der Slink Laurine L, Mourad Selma M
Аннотация
OBJECTIVE: To evaluate the implementation of home-administered intravenous rehydration for patients with hyperemesis gravidarum (HG) as an alternative to hospital admission.
DESIGN: Prospective cohort study.
METHOD: Between 11 July 2022 and 1 January 2025, patients with HG requiring intravenous fluids were treated at home. Patient satisfaction was assessed using a structured questionnaire. Primary outcomes were the number of avoided hospital admission days and patient satisfaction.
RESULTS: A total of 167 patients received home-administered rehydration, covering 246 treatment episodes and 1,989 treatment days. In 89% of cases rehydration could be administered at home, either fully or partly, resulting in an estimated reduction of 566 inpatient days. In 66% of cases, a single treatment episode was sufficient. Patient satisfaction was high.
CONCLUSION: Home-administered therapy for HG significantly reduced hospital admissions while maintaining high patient satisfaction. The organizational framework we developed may serve as a template for other low-complexity conditions requiring intravenous therapy in the home setting.
DESIGN: Prospective cohort study.
METHOD: Between 11 July 2022 and 1 January 2025, patients with HG requiring intravenous fluids were treated at home. Patient satisfaction was assessed using a structured questionnaire. Primary outcomes were the number of avoided hospital admission days and patient satisfaction.
RESULTS: A total of 167 patients received home-administered rehydration, covering 246 treatment episodes and 1,989 treatment days. In 89% of cases rehydration could be administered at home, either fully or partly, resulting in an estimated reduction of 566 inpatient days. In 66% of cases, a single treatment episode was sufficient. Patient satisfaction was high.
CONCLUSION: Home-administered therapy for HG significantly reduced hospital admissions while maintaining high patient satisfaction. The organizational framework we developed may serve as a template for other low-complexity conditions requiring intravenous therapy in the home setting.